Symptomatic treatment of mild to moderate pain and/or fever. This presentation is reserved for adults and children weighing at least 27 kg (approximately 8 years old).

Short-term treatment of moderate pain, particularly in the postoperative period, and short-term treatment of fever when the intravenous route is clinically justified by the urgency of treating pain or hyperthermia and/or when other routes of administration are not possible.

Short-term treatment of moderate pain, particularly in the postoperative period, and short-term treatment of fever when the intravenous route is clinically justified by the urgency of treating pain or hyperthermia and/or when other routes of administration are not possible.

Symptomatic treatment of mild to moderate pain and/or fever.

This presentation is reserved for adults and children weighing at least 27 kg (approximately 8 years old).

Symptomatic treatment of moderate to severe pain that is not responsive to the use of peripheral analgesics used alone.

Symptomatic treatment of moderate to severe pain that is not responsive to the use of peripheral analgesics used alone.

Symptomatic treatment of mild to moderate pain and/or febrile states.

SYNALVIC is indicated for the symptomatic treatment of moderate to severe pain.

The use of SYNALVIC should be limited to patients whose moderate to severe pain requires treatment with a combination of paracetamol and tramadol.

Major depressive episodes (characterized) including severe episodes in hospitalized patients.

Major depressive episodes (characterized) including severe episodes in hospitalized patients.